Skip to content

Public FDA record

Z-0496-05: Proven Porous CR Femur. Implantable orthopedic device

Recall record Z-0496-05 for Stelkast Co. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0496-05
Company in FDA record
Stelkast Co
FDA classification date
Feb 3, 2005
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Sterility may be compromised. The inner pouch of the implant packaging was sticking out beyond the seal of the outer pouch

Source facts

Action
The recalling firm telephoned their customers 9/24/04 to inform them of the problem and the need to return the product. As a follow up to the telephone call, the recalling firm sent fax notifications to their customers. The medical supply companies were instructed to contact their customers.
Initiated
2004-09-24
Root cause
Other
Terminated
2005-02-07
Distribution
The product was shipped to medical supply companies in CA, MO, NC, and WV and sales representatives in AZ , NC and PA.
Recall number
Z-0496-05
Recall status
Terminated
CDRH record ID
35614
FDA classified
2005-02-03
Recall event number
30287

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗